Projects

Thanks to its intellectual assets of 207,000 extracts and 20,000 strains, an enormous potential to be subjected to screening activities, the Foundation strongly believes in the possibility of discovering and developing new drugs and new therapies. For this reason, the Foundation invests heavily in its own research activities, through a team of highly experienced researchers from Pfizer Vicuron.